Chin Mark

CIK 00017343895 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001734389

Recent Transactions

50 trades

Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2025-06-11+10,000→ 10,000 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2024-06-12+10,000→ 10,000 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−2,300→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−2,033→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock
2024-03-11−13,224→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−1,016→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−3,214→ 0 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2024-03-08+424→ 13,224 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2024-01-01+1,072→ 12,801 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-11-27+5,000→ 11,729 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-10-01+3,035→ 6,729 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-07-01+18,656→ 36,941 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2023-06-22+23,000→ 23,000 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-06-15+15,853→ 18,306 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-06-15−15,853→ 0 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2023-06-09+7,136→ 7,136 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-04-01+18,285→ 18,285 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2022-12-29+7,000→ 7,000 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2022-06-23+36,798→ 36,798 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-06-23−36,798→ 0 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2022-06-22$1.40/sh+32,142→ 32,142 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2022-06-22+10,167→ 10,167 total
Award
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-06-15$0.01/sh+237,795→ 237,795 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Options (Right to Buy)
2022-06-02+8,500→ 8,500 total
Sale
Pyxis Oncology, Inc.$PYXS
Common Stock
2022-04-21$3.05/sh−1,745,761→ 0 total
Award
Pyxis Oncology, Inc.$PYXS
Common Stock
2022-03-31+66,831→ 66,831 total
Conversion
Pyxis Oncology, Inc.$PYXS
Common Stock
2021-10-13+1,433,261→ 1,433,261 total
Purchase
Pyxis Oncology, Inc.$PYXS
Common Stock
2021-10-13$16.00/sh+312,500→ 1,745,761 total
Conversion
Pyxis Oncology, Inc.$PYXS
Series B Convertible Preferred Stock
2021-10-13−9,114,109→ 0 total
Award
Pyxis Oncology, Inc.$PYXS
Stock Option (Right to buy)
2021-10-07+42,191→ 42,191 total
Purchase
Enliven Therapeutics, Inc.$ELVN
Common Stock
2021-07-16$6.00/sh+1,333,333→ 2,344,072 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Options (Right to Buy)
2021-06-29+7,728→ 7,728 total
Award
Iterum Therapeutics plc$ITRM
Restricted Stock Units
2021-06-23+36,798→ 36,798 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+3,017→ 3,017 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+2,438→ 2,438 total
Other
Iterum Therapeutics plc$ITRM
Ordinary Shares
2020-07-28−11,857→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Stock Units
2020-07-01−5,703→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2020-07-01+5,703→ 11,857 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2020-05-28+10,167→ 10,167 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2020-05-28+3,017→ 3,017 total
Other
Iterum Therapeutics plc$ITRM
Ordinary Shares
2020-04-07−1,089,903→ 0 total
Other
Iterum Therapeutics plc$ITRM
6.500% Exchangeable Senior Subordinated Note due 2025
2020-04-07→ 0 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2020-03-16+15,457→ 15,457 total
Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2020-03-16+1,367,058→ 1,367,058 total
Purchase
Enliven Therapeutics, Inc.$ELVN
Common Stock
2020-03-16$16.00/sh+187,500→ 1,554,558 total
Conversion
Enliven Therapeutics, Inc.$ELVN
Series B Preferred Stock
2020-03-16−8,611,110→ 0 total
Award
Iterum Therapeutics plc$ITRM
6.500% Exchangeable Senior Subordinated Note due 2025
2020-01-21$1900000.00/sh
Sale
Harpoon Therapeutics, Inc.
Common Stock
2019-12-17$16.83/sh−12,476→ 2,572,359 total

Companies

Recent Filings

Address

C/O DISC MEDICINE, INC. 321 ARSENAL STREET, SUITE 101

WATERTOWN, MA, 02472

View on SEC.gov